Literature DB >> 9399719

Comparison of power- and temperature-guided radiofrequency modification of the atrioventricular node. Polaris Investigator Group.

N G Kavesh1, M R Gosnell, S R Shorofsky, M R Gold.   

Abstract

The purpose of this study was to compare the performance and clinical outcome of radiofrequency ablation of the substrate of atrioventricular (AV) nodal reentrant tachycardia (AVNRT) when guided by power output or temperature monitoring. Two sequential multicenter studies of power-controlled and open-loop, temperature-controlled radiofrequency ablation were analyzed in 171 patients undergoing AV node modification for the treatment of AVNRT. After successful ablation of AVNRT, complete elimination of slow AV node pathway function was accomplished more often with than without temperature monitoring (92% vs 69%, p = 0.005). Greater power was delivered to each patient with than without temperature monitoring (median 47 W, range 10 to 57, vs median 35 W, range 5 to 68, p = 0.001). Acute elimination of tachycardia (100% vs 96%), 3-month recurrence (6% vs 8%), procedural times (162 vs 170 minutes), fluoroscopy times (24.6 vs 29.5 minutes), complications (6% vs 3%), and catheter removals to check for coagulum (8% vs 6%) did not differ between patients treated with and without temperature monitoring, respectively. Power- and temperature-controlled radiofrequency techniques are highly successful with low complication rates for slow pathway ablation. Temperature monitoring may allow the safe delivery of more power, and the more complete elimination of slow AV node pathway function.

Entities:  

Mesh:

Year:  1997        PMID: 9399719     DOI: 10.1016/s0002-9149(97)00723-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  1 in total

1.  Time-limited cryomapping during tachycardia: improved long-term outcomes for cryoablation of AVNRT.

Authors:  Paula L S Eryazici; Mansour Razminia; Oliver D'Silva; Jaime R Chavez; Ferah D Ciftci; Marianne Turner; Theodore Wang; Terry A Zheutlin; Richard F Kehoe
Journal:  J Interv Card Electrophysiol       Date:  2016-05-25       Impact factor: 1.900

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.